Background Optimising population-based cervical screening policies is becoming more
complex due to the expanding range of screening technologies available and the interplay …

Cytology-based screening has reduced cervical cancer mortality in countries able to
implement, sustain and financially support organized programs that achieve broad …

In the last two decades, computer-based models of cervical cancer screening have been
used to evaluate the cost-effectiveness of different secondary prevention policies. Analyses …

Background: Forthcoming cervical cancer screening strategies involving human
papillomavirus (HPV) testing for women not vaccinated against HPV infections may increase …

Importance Cervical cancer screening is a lifesaving intervention, with an array of
approaches, including liquid-based cytology (LBC), molecular testing for human …

Background Regarding primary and secondary cervical cancer prevention, the World Health
Organization proposed the cervical cancer elimination strategy that requires countries to …

Background Persistent infections with high-risk types of human papillomavirus (HPV) are
associated with the development of cervical neoplasia. Compared to cytology HPV testing is …

Primary HPV screening enables earlier diagnosis of cervical lesions compared to cytology,
however, its effect on the risk of treatment and adverse obstetric outcomes has not been …

Background Sweden revised their cervical cancer screening program in 2017 to include
cytology-based screening for women aged 23–29 years and primary human papillomavirus …

Background: In Canada, discussion about changing from cytology to human papillomavirus
(HPV) DNA testing for primary screening in cervical cancer is ongoing. However, the …